Connect with us
The presentation of the results was scheduled for the end of February, but Grifols wants to move forward so that the situation is not unsustainable for...
The intraday minimum was marked at 10:31 a.m., with 8.22 euros, after the stock spent an hour and a half in a volatility auction trying to...
Grifols is a listed Catalan pharmaceutical company. The company's activity focuses on the research, development, manufacturing, and marketing of products derived from plasma (blood products), intravenous therapy...
Reig Jofre is the only one that does not follow the upward trend of the Spanish pharmaceutical sector and closes the third quarter with a decrease...
In recent years, Grifols has invested in its innovation infrastructure and currently has more than 1,200 people who work together in four global research centers. In 2021,...
Grifols is a publicly traded Catalan pharmaceutical company. The company's activity is focused on the research, development, manufacturing, and marketing of plasma-derived products (blood products), intravenous...
Grifols has lost around 70% of its market value since the start of the pandemic. In the eyes of investors, its main burdens are debt, which...
The six listed pharmaceutical companies closed the first quarter with a stock market value of €9.5 billion, compared to €10.6 billion at the close of the...
Grifols will reduce the workforce of its industrial plasma business in the United States, its core business, affecting 2,000 workers by 2023. In addition, in corporate...
Janssen increased its profit to €72.2 million last year. In total, Johnson&Johnson expects year-end revenue to be between $93 billion and $93.5 billion, while it expects...